NCT05013996 (EV-AICS) is a NA clinical trial of MIDSA in Offense, Sex, sponsored by University Hospital, Tours.

Who is sponsoring NCT05013996?

NCT05013996 is sponsored by University Hospital, Tours.

What drugs are being tested in NCT05013996?

Interventions in NCT05013996: MIDSA, Usual methods of evaluation.

What condition does NCT05013996 study?

NCT05013996 studies Offense, Sex.

Is NCT05013996 still recruiting?

NCT05013996 is currently terminated. Last updated 24 November 2025.

Last reviewed 2025-11-24 · How we verify

NCT05013996: EV-AICS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of a Structured Clinical Assessment MIDSA, Its Feedback and Support for Change on Commitment to Care of Perpetrators of Sexual Offenses

Terminated NA Last updated 24 November 2025

What this trial tests

NA trial testing MIDSA in Offense, Sex in 10 participants. Terminated before completion.

Timeline

20 January 2022

Primary endpoint
14 January 2025

14 January 2025

Quick facts

Lead sponsor	University Hospital, Tours
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	10
Start date	20 January 2022
Primary completion	14 January 2025
Estimated completion	14 January 2025
Sites	5 locations across France

Drugs / interventions tested

MIDSA
Usual methods of evaluation

Conditions studied

Offense, Sex — all drugs for Offense, Sex →

Sponsor

University Hospital, Tours

Who can join

18 and older, male only, with Offense, Sex. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the effectiveness of an intervention including the clinical assessment carried out with the (Multidimensional Inventory of Development, Sex, and Aggression) MIDSA and the review of the results with the professional in charge of the subject on the adherence and commitment to the care of the sexual offenders.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Tours trials

Trials by the same sponsor.

NCT07452978 — Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence · Phase 2 · not yet recruiting
NCT07443800 — Comorbidity Between Attention Deficit Hyperactivity Disorder and Fibromyalgia · NA · not yet recruiting
NCT07251530 — Communication Enhancement Among Ventilated Patients in Intensive Care · not yet recruiting
NCT07189338 — Apneic Oxygenation With High-flow Nasal Oxygenation After Preoxygenation With Noninvasive Ventilation Before Intubation · NA · not yet recruiting
NCT07054112 — Efficacy of Live Online Course Mindfulness Program on Perceived Fatigue in Hemodialysis Patients · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05013996 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Tours
Last refreshed: 24 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05013996.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing